Log in | Register

Src tyrosine kinase inhibition prevents pulmonary ischemia–reperfusion-induced acute lung injury

Takeshi Oyaizu| Shan-Yu Fung| Atsushi Shiozaki| Zehong Guan| Qiao Zhang| Claudia C. dos Santos| Bing Han| Marco Mura| Shaf Keshavjee| Mingyao Liu
Experimental
Volume 38, Issue 5 / May , 2012

Pages 894 - 905

Abstract

Purpose

Pulmonary ischemia–reperfusion is a pathological process seen in several clinical conditions, including lung transplantation, cardiopulmonary bypass, resuscitation for circulatory arrest, atherosclerosis, and pulmonary embolism. A better understanding of its molecular mechanisms is very important.

Methods

Rat left lung underwent in situ ischemia for 60 min, followed by 2 h of reperfusion. The gene expression profiles and Src protein tyrosine kinase (PTK) phosphorylation were studied over time, and PP2, an Src PTK inhibitor, was intravenously administered 10 min before lung ischemia to determine the role of Src PTK in lung injury.

Results

Reperfusion following ischemia significantly changed the expression of 169 genes, with Mmp8, Mmp9, S100a9, and S100a8 being the most upregulated genes. Ischemia alone only affected expression of 9 genes in the lung. However, Src PTK phosphorylation (activation) was increased in the ischemic lung, mainly on the alveolar wall. Src PTK inhibitor pretreatment decreased phosphorylation of Src PTKs, total protein tyrosine phosphorylation, and STAT3 phosphorylation. It increased phosphorylation of the p85α subunit of PI3 kinase, a signal pathway that can inhibit coagulation and inflammation. PP2 reduced leukocyte infiltration in the lung, apoptotic cell death, fibrin deposition, and severity of acute lung injury after reperfusion. Src inhibition also significantly reduced CXCL1 (GRO/KI) and CCL2 (MCP-1) chemokine levels in the serum.

Conclusion

During pulmonary ischemia, Src PTK activation, rather than alteration in gene expression, may play a critical role in reperfusion-induced lung injury. Src PTK inhibition presents a new prophylactic treatment for pulmonary ischemia–reperfusion-induced acute lung injury.

Keywords

References

  1. den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL (2010) Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 299:H1283–H1299
    • View reference on publisher's website
  2. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND (2009) Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 179:220–227
    • View reference on PubMed
    • View reference on publisher's website
  3. Loehe F, Mueller C, Annecke T, Minor T, Bittmann I, Krombach F, Messmer K (2002) Tissue damage of non-heart-beating donor lungs after long-term preservation: evaluation of histologic alteration, bronchoalveolar lavage, and energy metabolism. Shock 17:502–507
    • View reference on PubMed
    • View reference on publisher's website
  4. Jin K, Mao XO, Eshoo MW, Nagayama T, Minami M, Simon RP, Greenberg DA (2001) Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann Neurol 50:93–103
    • View reference on PubMed
    • View reference on publisher's website
  5. Buttner F, Cordes C, Gerlach F, Heimann A, Alessandri B, Luxemburger U, Tureci O, Hankeln T, Kempski O, Burmester T (2009) Genomic response of the rat brain to global ischemia and reperfusion. Brain Res 1252:1–14
    • View reference on PubMed
    • View reference on publisher's website
  6. Stegall MD, Park WD, Kim DY, Covarrubias M, Khair A, Kremers WK (2002) Changes in intragraft gene expression secondary to ischemia reperfusion after cardiac transplantation. Transplantation 74:924–930
    • View reference on PubMed
    • View reference on publisher's website
  7. Amberger A, Schneeberger S, Hernegger G, Brandacher G, Obrist P, Lackner P, Margreiter R, Mark W (2002) Gene expression profiling of prolonged cold ischemia and reperfusion in murine heart transplants. Transplantation 74:1441–1449
    • View reference on PubMed
    • View reference on publisher's website
  8. Yoshida T, Kurella M, Beato F, Min H, Ingelfinger JR, Stears RL, Swinford RD, Gullans SR, Tang SS (2002) Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. Kidney Int 61:1646–1654
    • View reference on PubMed
    • View reference on publisher's website
  9. Yamane M, Liu M, Kaneda H, Uhlig S, Waddell TK, Keshavjee S (2005) Reperfusion-induced gene expression profiles in rat lung transplantation. Am J Transplant 5:2160–2169
    • View reference on PubMed
    • View reference on publisher's website
  10. Anraku M, Cameron MJ, Waddell TK, Liu M, Arenovich T, Sato M, Cypel M, Pierre AF, de Perrot M, Kelvin DJ, Keshavjee S (2008) Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. Am J Transplant 8:2140–2148
    • View reference on PubMed
    • View reference on publisher's website
  11. Okutani D, Lodyga M, Han B, Liu M (2006) Src protein tyrosine kinase family and acute inflammatory responses. Am J Physiol Lung Cell Mol Physiol 291:L129–L141
    • View reference on PubMed
    • View reference on publisher's website
  12. Thomas SM, Brugge JS (1997) Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513–609
    • View reference on PubMed
    • View reference on publisher's website
  13. Paul R, Zhang ZG, Eliceiri BP, Jiang Q, Boccia AD, Zhang RL, Chopp M, Cheresh DA (2001) Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 7:222–227
    • View reference on PubMed
    • View reference on publisher's website
  14. Lennmyr F, Ericsson A, Gerwins P, Akterin S, Ahlstrom H, Terent A (2004) Src family kinase-inhibitor PP2 reduces focal ischemic brain injury. Acta Neurol Scand 110:175–179
    • View reference on PubMed
    • View reference on publisher's website
  15. Takeishi Y, Huang Q, Wang T, Glassman M, Yoshizumi M, Baines CP, Lee JD, Kawakatsu H, Che W, Lerner-Marmarosh N, Zhang C, Yan C, Ohta S, Walsh RA, Berk BC, Abe J (2001) Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning. J Mol Cell Cardiol 33:1989–2005
    • View reference on PubMed
    • View reference on publisher's website
  16. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, Burstein D, Doukas J, Soll R, Losordo D, Cheresh D (2004) Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113:885–894
    • View reference on PubMed
  17. Cursio R, Miele C, Filippa N, Van Obberghen E, Gugenheim J (2006) Alterations in protein tyrosine kinase pathways in rat liver following normothermic ischemia-reperfusion. Transplant Proc 38:3362–3365
    • View reference on PubMed
    • View reference on publisher's website
  18. Takikita-Suzuki M, Haneda M, Sasahara M, Owada MK, Nakagawa T, Isono M, Takikita S, Koya D, Ogasawara K, Kikkawa R (2003) Activation of Src kinase in platelet-derived growth factor-B-dependent tubular regeneration after acute ischemic renal injury. Am J Pathol 163:277–286
    • View reference on PubMed
    • View reference on publisher's website
  19. Baldwin C, Chen ZW, Bedirian A, Yokota N, Nasr SH, Rabb H, Lemay S (2006) Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases. Am J Physiol Renal Physiol 291:F960–F971
    • View reference on PubMed
    • View reference on publisher's website
  20. Severgnini M, Takahashi S, Tu P, Perides G, Homer RJ, Jhung JW, Bhavsar D, Cochran BH, Simon AR (2005) Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury. Am J Respir Crit Care Med 171:858–867
    • View reference on PubMed
    • View reference on publisher's website
  21. Fung S-Y, Oyaizu T, Yang H, Han B, Keshavjee S, Liu M (2011) The potential of nanoscale combination of self-assembling peptide and amino acids of the Src tyrosine kinase inhibitor in acute lung injury. Biomaterials 32:4000–4008
    • View reference on PubMed
    • View reference on publisher's website
  22. Keshavjee S, Zhang XM, Fischer S, Liu M (2000) Ischemia reperfusion-induced dynamic changes of protein tyrosine phosphorylation during human lung transplantation. Transplantation 70:525–531
    • View reference on PubMed
    • View reference on publisher's website
  23. Sakiyama S, dePerrot M, Han B, Waddell TK, Keshavjee S, Liu M (2003) Ischemia-reperfusion decreases protein tyrosine phosphorylation and p38 mitogen-activated protein kinase phosphorylation in rat lung transplants. J Heart Lung Transpl 22:338–346
    • View reference on publisher's website
  24. Khadaroo RG, He R, Parodo J, Powers KA, Marshall JC, Kapus A, Rotstein OD (2004) The role of the Src family of tyrosine kinases after oxidant-induced lung injury in vivo. Surgery 136:483–488
    • View reference on PubMed
    • View reference on publisher's website
  25. Okutani D, Han B, Mura M, Waddell TK, Keshavjee S, Liu M (2007) High-volume ventilation induces pentraxin 3 expression in multiple acute lung injury models in rats. Am J Physiol Lung Cell Mol Physiol 292:L144–L153
    • View reference on PubMed
    • View reference on publisher's website
  26. He X, Han B, Mura M, Li L, Cypel M, Soderman A, Picha K, Yang J, Liu M (2008) Anti-human tissue factor antibody ameliorated intestinal ischemia reperfusion-induced acute lung injury in human tissue factor knock-in mice. PLoS One 3:e1527
    • View reference on PubMed
    • View reference on publisher's website
  27. Han B, Haitsma JJ, Zhang Y, Bai X, Rubacha M, Keshavjee S, Zhang H, Liu M (2011) Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury. Intensive Care Med 37:334–342
  28. He X, Han B, Bai X, Zhang Y, Cypel M, Mura M, Keshavjee S, Liu M (2010) PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation. Intensive Care Med 36:356–364
  29. Mura M, Andrade CF, Han B, Seth R, Zhang Y, Bai XH, Waddell TK, Hwang D, Keshavjee S, Liu M (2007) Intestinal ischemia-reperfusion-induced acute lung injury and oncotic cell death in multiple organs. Shock 28:227–238
    • View reference on PubMed
    • View reference on publisher's website
  30. Mura M, Binnie M, Han B, Li C, Andrade CF, Shiozaki A, Zhang Y, Ferrara N, Hwang D, Waddell TK, Keshavjee S, Liu M (2010) Functions of type II pneumocyte-derived vascular endothelial growth factor in alveolar structure, acute inflammation, and vascular permeability. Am J Pathol 176:1725–1734
    • View reference on PubMed
    • View reference on publisher's website
  31. dos Santos CC, Okutani D, Hu P, Han B, Crimi E, He X, Keshavjee S, Greenwood C, Slutsky AS, Zhang H, Liu M (2008) Differential gene profiling in acute lung injury identifies injury-specific gene expression. Crit Care Med 36:855–865
    • View reference on PubMed
    • View reference on publisher's website
  32. Shiozaki A, Lodyga M, Bai X, Nadesalingam J, Oyaizu T, Winer D, Asa SL, Keshavjee S, Liu M (2011) XB130, a novel adaptor protein, promotes thyroid tumor growth. Am J Pathol 178:391–401
    • View reference on PubMed
    • View reference on publisher's website
  33. Cardella JA, Keshavjee SH, Bai XH, Yeoh JS, Granton JT, Meade MO, Matte-Martyn A, Waddell TK, Liu M (2004) Increased expression of nitric oxide synthase in human lung transplants after nitric oxide inhalation. Transplantation 77:886–890
    • View reference on PubMed
    • View reference on publisher's website
  34. Sagan D, Eckardt-Schupp F, Eichholtz-Wirth H (2008) Reduced expression of SRC family kinases decreases PI3K activity in NBS1−/− lymphoblasts. Biochem Biophys Res Commun 377:181–186
    • View reference on PubMed
    • View reference on publisher's website
  35. Schabbauer G, Tencati M, Pedersen B, Pawlinski R, Mackman N (2004) PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler Thromb Vasc Biol 24:1963–1969
    • View reference on PubMed
    • View reference on publisher's website
  36. dos Santos CC, Han B, Andrade CF, Bai X, Uhlig S, Hubmayr R, Tsang M, Lodyga M, Keshavjee S, Slutsky AS, Liu M (2004) DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch. Physiol Genomics 19:331–342
    • View reference on PubMed
    • View reference on publisher's website
  37. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499–2513
    • View reference on PubMed
    • View reference on publisher's website
  38. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B (2009) Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171:59–76
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement